House GOP Proposes ACA Health Plan Changes as Enhanced Subsidies Set to Expire

Congress is approaching a critical deadline as enhanced Affordable Care Act (ACA) tax subsidies, which help lower insurance premiums for millions of Americans, are set to expire at the end of the year. The Senate recently failed to advance both Republican and Democratic health care proposals aimed at addressing this issue. Now, the House of Representatives is considering a new Republican health care package that excludes an extension of these enhanced ACA subsidies. The House Republican plan primarily focuses on long-standing GOP proposals such as expanding access to association health plans, which would allow small businesses and self-employed individuals to band together for potentially lower-cost coverage. The plan also seeks increased transparency from pharmacy benefit managers (PBMs) in an effort to control drug costs, addressing concerns about PBMs' impact on independent pharmacies and overall drug pricing. However, the GOP proposal delays implementation of cost-sharing reductions for some lower-income ACA enrollees until 2027 and does not include an extension of the enhanced ACA tax credits set to expire on December 31. Without these subsidies, many families face significantly higher premiums next year. Alternative proposals from more moderate House Republicans and Democrats aim to extend the subsidies temporarily to prevent premium spikes. These efforts include bipartisan discharge petitions to force floor votes, though their success depends on leadership support. Democrats advocate for a clean three-year extension of the enhanced subsidies, but Republicans have signaled opposition to such measures without program changes. The legislative standoff leaves uncertain the immediate future of ACA subsidy levels and health insurance affordability. The debate reflects broader party differences on health care policy, involving regulatory oversight of PBMs, support for employer-based insurance options, and approaches to market-driven versus federally supported coverage. As the congressional session nears its end, insurance industry professionals and policy stakeholders closely monitor these developments given their implications for premium affordability, market stability, and health plan design. The unfolding negotiations underscore ongoing challenges in achieving bipartisan solutions to health care costs and access within the U.S. insurance landscape.